Home Portfolio Clinical Trials
Clinical Trials
Ongoing Clinical Trials
Drug Indication Topic
Indolent B-Cell Non-Hodgkin Lymphoma
A study of BI-1206 in combination with Rituximab in subject with indolent B-cell Non-Hodgkin Lymphoma
Upcoming Clinical Trials
Drug Indication Topic
Multiple Myeloma
To evaluate the efficacy and safety of CID-103 for treatment of Multiple Myeloma
Drug Indication Topic
Relapse/Refractory Multiple Myeloma
A study of CB-5339 in relapse/refractory multiple myeloma patients
For more information on trials conducted by our partners for CNCT19 and BI-1206, please refer to clinicaltrials.gov.